An Open-Label Study to Evaluate the Safety and Tolerability and to Explore the Efficacy of Avonex (Interferon Beta-1a) in Chinese Subjects With Relapsing Multiple Sclerosis
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007180/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study is designed to determine the effect of weekly intramuscular (IM) administration of
30 mcg Avonex (interferon beta 1a) on safety parameters and gadolinium (Gd) enhanced and
T2-weighted cranial magnetic resonance imaging (MRI) lesions in Chinese patients with
clinically diagnosed (using revised McDonald criteria) relapsing multiple sclerosis (MS).
提供机构：
Vivli
创建时间：
2021-06-10
